These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15515421)

  • 1. Treatment of chronic low back pain with tropisetron.
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2004; 119():76-8. PubMed ID: 15515421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
    Färber L; Stratz TH; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Welzel D; Müller W;
    Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
    Färber L; Stratz T; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Alten R; Müller W
    Scand J Rheumatol Suppl; 2000; 113():49-54. PubMed ID: 11028832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron.
    Müller W; Stratz T
    Scand J Rheumatol Suppl; 2004; 119():44-8. PubMed ID: 15515413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients.
    Neziri AY; Dickenmann M; Scaramozzino P; Andersen OK; Arendt-Nielsen L; Dickenson AH; Curatolo M
    Pain; 2012 Feb; 153(2):311-318. PubMed ID: 22100357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pain modification by the 5-HT3 receptor antagonist tropisetron in secondary fibromyalgias].
    Stratz T; Müller W
    Fortschr Med Orig; 2002; 120(1):17-20. PubMed ID: 14518353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibromyalgia treatment with intravenous tropisetron administration.
    Stratz T; Färber L; Varga B; Baumgartner C; Haus U; Müller W
    Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the intravenous administration of tropisetron in fibromyalgia patients.
    Müller W; Stratz T
    Scand J Rheumatol Suppl; 2000; 113():59-62. PubMed ID: 11028834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of 5-HT3 receptor antagonists in various rheumatic diseases--a clue to the mechanism of action of these agents in fibromyalgia?
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2000; 113():66-71. PubMed ID: 11028836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain.
    Haus U; Varga B; Stratz T; Späth M; Müller W
    Scand J Rheumatol Suppl; 2000; 113():55-8. PubMed ID: 11028833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local treatment of tendinopathies: a comparison between tropisetron and depot corticosteroids combined with local anesthetics.
    Stratz Th; Färber L; Müller W
    Scand J Rheumatol; 2002; 31(6):366-70. PubMed ID: 12492253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions--preliminary clinical experience.
    Hrycaj P
    Scand J Rheumatol Suppl; 2004; 119():55-8. PubMed ID: 15515416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropisetron for postoperative nausea and vomiting in patients after gynaecological surgery.
    Zomers PJ; Langenberg CJ; de Bruijn KM
    Br J Anaesth; 1993 Nov; 71(5):677-80. PubMed ID: 8251279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.
    Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W
    Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron].
    Stratz T; Müller W
    Schmerz; 2003 Jun; 17(3):200-3. PubMed ID: 12789487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].
    Zhang WD; Wang XW; Chen ZD; Qin FZ; Shu YQ; Pan LX; Zhang MH
    Ai Zheng; 2007 Aug; 26(8):870-3. PubMed ID: 17697550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of systemic sclerosis with the 5-HT3 receptor antagonist tropisetron.
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2004; 119():59-62. PubMed ID: 15515417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do cytochrome enzymes influence the therapeutic effect of tropisetron in fibromyalgia?
    Stratz T; Kees F; Müller W
    Drugs Exp Clin Res; 2003; 29(2):91-4. PubMed ID: 12951840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of tendopathies with tropisetron.
    Stratz T; Varga B; Müller W
    Rheumatol Int; 2002 Nov; 22(6):219-21. PubMed ID: 12426658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.